Schedule 13G ownership disclosure
BICYCLE THERAPEUTICS PLC
Ordinary Shares, nominal value GBP 0.01 per share · CUSIP: 088786108
Event date: 2026-02-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Invus Public Equities, L.P.
Shares: 2,719,707.00 · Class: 5.4%
- Invus Public Equities Advisors, LLC
Shares: 2,719,707.00 · Class: 5.4%
- Invus Global Management, LLC
Shares: 2,719,707.00 · Class: 5.4%
- Siren, L.L.C.
Shares: 2,719,707.00 · Class: 5.4%
- Avicenna Life Sci Master Fund LP
Shares: 429,342.00 · Class: 0.9%
- Avicenna Life Sci Master GP LLC
Shares: 429,342.00 · Class: 0.9%
- Ulys, L.L.C.
Shares: 429,342.00 · Class: 0.9%
- Raymond Debbane
Shares: 3,149,049.00 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002005369-26-000016
- Form type
- SCHEDULE 13G
- Filer
- BICYCLE THERAPEUTICS PLC
- CIK
- CIK 1761612
- Filed
- Mar 03, 2026
- Reporting period
- Feb 25, 2026
- Description
- Schedule 13G beneficial ownership